Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01462734
Other study ID # No. 461
Secondary ID
Status Completed
Phase N/A
First received October 26, 2011
Last updated March 31, 2015
Start date October 2011

Study information

Verified date March 2015
Source Kyorin University
Contact n/a
Is FDA regulated No
Health authority Japan: Institutional Review Board
Study type Observational

Clinical Trial Summary

MicroRNAs are important regulators of many cellular functions but their expression profile in human vitreous is still unclear. Aim of this study is to investigate microRNA expression profile by PCR in human vitreous of macula hole patients which is suggested to be similar to that of healthy patients.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Female macula hole patients without previous ocular or systemic disease.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms

  • MicroRNA Expression Profile in Human Vitreous

Intervention

Procedure:
human vitreous and blood serum sampling, PCR
1ml of human vitreous and 3ml of human blood serum

Locations

Country Name City State
Japan Kyorin University School Of Medicine Tokyo Mitakasi Sinkawa6-20-2

Sponsors (1)

Lead Sponsor Collaborator
Kyorin University

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary MicroRNA expression profile in human vitreous investigated by PCR 1month No